Novoprotein(SH:688137) Zhong Guo Jing Ji Wang·2025-07-09 06:33Group 1 - Nearshore Protein (688137.SH) announced a share reduction plan by shareholders holding less than 5% of the company's shares [1] - Shareholder Heze Qiaobei plans to reduce holdings by up to 161,959 shares, representing a maximum of 0.2308% of total shares [2] - Shareholder Shanghai Pujin plans to reduce holdings by up to 263,158 shares, representing a maximum of 0.3750% of total shares [2] Group 2 - The reduction period for both shareholders is from July 14, 2025, to October 13, 2025 [2] - The shares to be reduced were acquired before the IPO, and the reason for the reduction is for their own operational development needs [2] - Nearshore Protein was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on September 29, 2022, with an initial offering price of 106.19 yuan per share [3] Group 3 - The total amount raised from the IPO was 1.8629825 billion yuan, with a net amount of 1.7421958 billion yuan after deducting issuance costs [3][4] - The company initially planned to raise 1.5 billion yuan, with the funds allocated for core diagnostic materials, innovative diagnostic reagent industrialization projects, research center construction, and working capital [4]